EFTA01008138.pdf

From: Charlotte Dequeker To: Charlotte Dequeker Bcc: [email protected] Subject: P5 Health Ventures - Q2 18 Letter Date: Wed, 22 Aug 2018 12:57:34 +0000 Attachments: P5 Health Ventures_-_Q2_18_-_Letter_to_Investors.pdf Good morning, Please see attached The P5 Health Ventures 2nd Quarter 2018 Letter to Investors. It provides updates on our most portfolio companies, new potential investments, market statistics and our capital raise efforts in which we are in the final stages. From our letter "Our portfolio is wellpositioned and will soon include our sLrth investment, a mental health and wellness platform. In summary, Coheres just completed a significant bridge round to its Series B next spring; Babyscripts signed a term sheetfor a round led by a major industrial conglomerate and in September will have thefirst (-I- a final) close; and, figur8 is advancing at a rapid clip with revenue to start in Q4 2018. On page 2, we address the portfolio companies in more detail. As to ourfundraising efforts, they are bearingfruit as we ramp toward a final close most likely by year-end. In that endeavor, we continue to refine our message down to the simplest (andfewest) words and images so that investors andfor that matter anyone can understand what we are investing in and why as well as what we expect to achieve." We hope this finds you all well. Regards, The PSHV Team If you wish to no longer receive these emails, please reply with "remove" in the text If you have any other questions, please also reply or email David directly at Charlotte Dequeker Investor Relations / Operations P5 Health Ventures o) c) Listen: Follow us on Subscribe: EFTA01008138